Pharmaceuticals

Europe Organ Transplant Immunosuppressant Drugs Market Report 2017

  • QYR908369
  • 123 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Organ Transplant Immunosuppressant Drugs

Revenue, means the sales value of Organ Transplant Immunosuppressant Drugs

This report studies sales (consumption) of Organ Transplant Immunosuppressant Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

AstellasPharma

Genzyme Corporation

Watson Pharmaceuticals

Novartis AG

Mylan Laboratories

GlaxoSmithKline plc

Hoffman La Roche

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Organ Transplant Immunosuppressant Drugs in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Zenapax

Prograf

Cellcept

Myfortic

Neoral

Other

Split by application, this report focuses on sales, market share and growth rate of Organ Transplant Immunosuppressant Drugs in each application, can be divided into

Heart Transplant

Lung Transplant

Kidney Transplant

Liver Transplant

Other

Table of Contents

Europe Organ Transplant Immunosuppressant Drugs Market Report 2017

1 Organ Transplant Immunosuppressant Drugs Overview

1.1 Product Overview and Scope of Organ Transplant Immunosuppressant Drugs

1.2 Classification of Organ Transplant Immunosuppressant Drugs

1.2.1 Zenapax

1.2.2 Prograf

1.2.3 Cellcept

1.2.4 Myfortic

1.2.5 Neoral

1.2.6 Other

1.3 Application of Organ Transplant Immunosuppressant Drugs

1.3.1 Heart Transplant

1.3.2 Lung Transplant

1.3.3 Kidney Transplant

1.3.4 Liver Transplant

1.3.5 Other

1.4 Organ Transplant Immunosuppressant Drugs Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Organ Transplant Immunosuppressant Drugs (2012-2022)

1.5.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2022)

1.5.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

2 Europe Organ Transplant Immunosuppressant Drugs by Manufacturers, Type and Application

2.1 Europe Organ Transplant Immunosuppressant Drugs Market Competition by Manufacturers

2.1.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Organ Transplant Immunosuppressant Drugs (Volume and Value) by Type

2.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)

2.3 Europe Organ Transplant Immunosuppressant Drugs (Volume and Value) by Countries

2.3.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2012-2017)

2.4 Europe Organ Transplant Immunosuppressant Drugs (Volume) by Application

3 Germany Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

3.1 Germany Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

3.1.1 Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

3.1.2 Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

3.1.3 Germany Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

3.2 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

3.3 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

3.4 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

4 France Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

4.1 France Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

4.1.1 France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

4.1.2 France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

4.1.4 France Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

4.2 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

4.3 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

4.4 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

5 UK Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

5.1 UK Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

5.1.1 UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

5.1.2 UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

5.1.5 UK Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

5.2 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

5.3 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

5.4 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

6 Russia Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

6.1 Russia Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

6.1.1 Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

6.1.2 Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

6.1.6 Russia Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

6.2 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

6.3 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

6.4 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

7 Italy Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

7.1 Italy Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

7.1.1 Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

7.1.2 Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

7.1.7 Italy Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

7.2 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

7.3 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

7.4 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

8 Spain Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

8.1 Spain Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

8.1.1 Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

8.1.2 Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

8.1.8 Spain Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

8.2 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

8.3 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

8.4 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

9 Benelux Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)

9.1 Benelux Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)

9.1.1 Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

9.1.2 Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

9.2 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers

9.3 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type

9.4 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application

10 Europe Organ Transplant Immunosuppressant Drugs Manufacturers Analysis

10.1 AstellasPharma

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.1.2.1 Zenapax

10.1.2.2 Prograf

10.1.3 AstellasPharma Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Genzyme Corporation

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.2.2.1 Zenapax

10.2.2.2 Prograf

10.2.3 Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Watson Pharmaceuticals

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.3.2.1 Zenapax

10.3.2.2 Prograf

10.3.3 Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Novartis AG

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.4.2.1 Zenapax

10.4.2.2 Prograf

10.4.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Mylan Laboratories

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.5.2.1 Zenapax

10.5.2.2 Prograf

10.5.3 Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 GlaxoSmithKline plc

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.6.2.1 Zenapax

10.6.2.2 Prograf

10.6.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Hoffman La Roche

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification

10.7.2.1 Zenapax

10.7.2.2 Prograf

10.7.3 Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

11 Organ Transplant Immunosuppressant Drugs Manufacturing Cost Analysis

11.1 Organ Transplant Immunosuppressant Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Organ Transplant Immunosuppressant Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Organ Transplant Immunosuppressant Drugs Market Forecast (2017-2022)

14.1 Germany Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.2 France Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.3 UK Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.4 Russia Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.5 Italy Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.6 Spain Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.7 Benelux Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)

14.8 Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2017-2022)

14.9 Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Organ Transplant Immunosuppressant Drugs

Table Classification of Organ Transplant Immunosuppressant Drugs

Figure Europe Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type in 2015

Figure Zenapax Picture

Figure Prograf Picture

Figure Cellcept Picture

Figure Myfortic Picture

Figure Neoral Picture

Figure Other Picture

Table Application of Organ Transplant Immunosuppressant Drugs

Figure Europe Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application in 2015

Figure Heart Transplant Examples

Figure Lung Transplant Examples

Figure Kidney Transplant Examples

Figure Liver Transplant Examples

Figure Other Examples

Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2022)

Figure Europe Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)

Table Europe Organ Transplant Immunosuppressant Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers

Figure 2016 Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers

Table Europe Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers

Table 2016 Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers

Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type (2012-2017)

Figure Europe Organ Transplant Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Type (2012-2017)

Figure Europe Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Countries (2012-2017)

Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Countries (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Countries (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application (2012-2017)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application (2012-2017)

Figure Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure Germany Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table Germany Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table Germany Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure France Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table France Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table France Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table France Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table France Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table France Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table France Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure UK Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table UK Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table UK Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table UK Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table UK Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table UK Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure Russia Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table Russia Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table Russia Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure Italy Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table Italy Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table Italy Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure Spain Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table Spain Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table Spain Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Figure Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)

Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)

Figure Benelux Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)

Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)

Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)

Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)

Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)

Table Organ Transplant Immunosuppressant Drugs Basic Information List

Table AstellasPharma Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AstellasPharma Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Genzyme Corporation Basic Information List

Table Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Watson Pharmaceuticals Basic Information List

Table Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Mylan Laboratories Basic Information List

Table Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table GlaxoSmithKline plc Basic Information List

Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Hoffman La Roche Basic Information List

Table Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Organ Transplant Immunosuppressant Drugs

Figure Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs

Figure Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis

Table Raw Materials Sources of Organ Transplant Immunosuppressant Drugs Major Manufacturers in 2015

Table Major Buyers of Organ Transplant Immunosuppressant Drugs

Table Distributors/Traders List

Figure Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2017-2022)

Table Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370